Table 2.
The pathogenicity scoring criteria | Score | |
---|---|---|
Variant described as pathogenic by more than one report | yes | 2 |
no | 0 | |
PhastCons conservation | yes | 1 |
no | 0 | |
PhyloP conservation | yes | 1 |
no | 0 | |
Heteroplasmy evidences | yes | 2 |
no | 0 | |
Segregation of mutation with disease | yes | 2 |
no | 0 | |
Histochemical evidence of mitochondrial disease | yes | 2 |
no | 0 | |
Biochemical defect in OXPHOS complexes I, III, IV | yes | 2 |
no | 0 | |
Pathogenicity evidence in trans‐mitochondrial cybrids or mutant mt‐tRNA steady‐state level studies | yes | 5 |
no | 0 | |
Evidence of mutation segregation with biochemical defect from single‐fiber studies | yes | 3 |
no | 0 |
Each of the criteria is associated with a weighted score allowing classification of human mitochondrial tRNA variant pathogenicity. The improvements applied in Preste et al., (2019) is focused on PhyloP and PhastCons usage to evaluate the inter‐mammalian site conservation.